CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-22 | Neermann Joerg Director | Grant or award · Stock Option | +29,959 | 29,959 | ||
| 2019-07-22 | Ossipow Vincent Director | Grant or award · Stock Option | +29,959 | 29,959 | ||
| 2019-07-22 | Nash Duane Director | Grant or award · Stock Option | +29,959 | 29,959 | ||
| 2019-01-11 | Cox Russell J. Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −1,588,832 | 0 | ||
| 2019-01-11 | Cox Russell J. Chief Executive Officer | Grant or award · Restricted Stock Units | +1,854,376 | 1,854,376 | ||
| 2019-01-11 | Ashley Robert A. Chief Scientific Officer, EVP | Returned to the company · Stock Option (right to buy) | −93,377 | 0 | ||
| 2019-01-11 | Ashley Robert A. Chief Scientific Officer, EVP | Returned to the company · Stock Option (right to buy) | −23,344 | 0 | ||
| 2019-01-11 | Ashley Robert A. Chief Scientific Officer, EVP | Returned to the company · Stock Option (right to buy) | −241,670 | 0 | ||
| 2019-01-11 | Ashley Robert A. Chief Scientific Officer, EVP | Returned to the company · Stock Option (right to buy) | −75,000 | 0 | ||
| 2019-01-11 | Ashley Robert A. Chief Scientific Officer, EVP | Returned to the company · Stock Option (right to buy) | −75,000 | 0 | ||
| 2019-01-11 | Ashley Robert A. Chief Scientific Officer, EVP | Returned to the company · Stock Option (right to buy) | −75,000 | 0 | ||
| 2019-01-11 | Ashley Robert A. Chief Scientific Officer, EVP | Grant or award · Restricted Stock Units | +816,634 | 816,634 | ||
| 2019-01-11 | Swanson Michael V. Chief Financial Officer, EVP | Returned to the company · Stock Option (right to buy) | −90,000 | 0 | ||
| 2019-01-11 | Swanson Michael V. Chief Financial Officer, EVP | Returned to the company · Stock Option (right to buy) | −75,000 | 0 | ||
| 2019-01-11 | Swanson Michael V. Chief Financial Officer, EVP | Returned to the company · Stock Option (right to buy) | −75,000 | 0 | ||
| 2019-01-11 | Swanson Michael V. Chief Financial Officer, EVP | Returned to the company · Stock Option (right to buy) | −75,000 | 0 | ||
| 2019-01-11 | Swanson Michael V. Chief Financial Officer, EVP | Grant or award · Restricted Stock Units | +817,826 | 817,826 | ||
| 2019-01-11 | DUNN JOHN MICHAEL General Counsel and Secretary | Returned to the company · Stock Option (right to buy) | −50,000 | 0 | ||
| 2019-01-11 | DUNN JOHN MICHAEL General Counsel and Secretary | Returned to the company · Stock Option (right to buy) | −45,000 | 0 | ||
| 2019-01-11 | DUNN JOHN MICHAEL General Counsel and Secretary | Returned to the company · Stock Option (right to buy) | −45,000 | 0 |
Page 12 of 16 · 311 trades